Abstract:Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor for treating type Ⅱ diabetes.In the process of synthesizing dapagliflozin, 5-bromo-2-chloropheny-4''-ethoxyldiphenylmethanone (compound 1) is a key intermediate.According to the literatures, there is always by-product 5-bromo-2-chloropheny-2''-ethoxyldiphenylmethanone (compound 2) in the synthesis procedure of compound 1.Due to the similarities of the two isomers in physical and chemical properties, it''s difficult to separate and differentiate compound 1 and 2.As compound 2 affects the purity of dapagliflozin, it is of great importance to establish a method to rapidly distinguish compound 1 from compound 2.In this article, high performance liquid chromatography-ion trap-time of flight mass spectrometry (HPLC-IT-TOF MS) method was used to analyze compound 1 and 2.The samples were dissolved in methanol for direct injection.Under the optimized chromatographic conditions, good separation for the two isomers was obtained on a Capcell PAK C18 column (250 mm×4.6 mm×5 μm) with a mobile phase of water (0.1% formic acid) and acetonitrile-methanol (3∶1, V/V) at a flow rate of 0.6 mL/min.The target compounds were assayed by IT-TOF MS/MS in positive mode with the spray voltage set at 1.77 kV.The nitrogen flow was set at 1.5 L/min, and the capillary temperature was set at 200 ℃.The collision gas was helium.The ion at m/z 338.97 was chosen as the target to perform MS/MS experiment, and the collision energies were set at 10%, 15%, 20% and 25%, respectively.The MS/MS results under different collision energies were gained simultaneously by setting events in parallel on IT-TOF mass spectrometer.In order to visually distinguish the two isomers, breakdown curves were mapped by [M+H]+ and fragment ions.The breakdown curves of the two isomers show significant differences, which provided strong support in this study.In addition, the element compositions of the three product ions were also confirmed by IT-TOF MS.Loss of C2H2 from the precursor ions of [M+H]+ was observed in the MS/MS spectra of both the isomers.For compound 1, the major fragmentation pathway was loss of C2H5OC6H5 from [M+H]+via a 2-step proton transfer.While, for compound 2, [M+H-C2H4O]+via 1-4 H shift from ortho-substituted ethoxy group to the benzene ring was found to be the major product ion.The difference in the fragmentation pathways of the two isomers may be due to the different substitution sites of the ethoxy groups.When the ethoxy group is ortho-substituted, the 2-step proton transfer is quite difficult.As a result, it goes through loss of C2H4O mainly.The method is simple, effective and accurate, which is suitable for rapidly qualitative and semi-quantitative analysis of the isomers, and also can provide a reliable and effective technique for the quality control of dapagliflozin.

Synthesis of Related Substances of Canagliflozin

New Synthetic Method of Pioglitazone Hydrochloride

Crystal Structure of Canagliflozin Hemihydrate

Improved Synthesis of 1-[Hexahydrocyclopenta[c]pyrrol-2(1h)-yl]-3-(4-methylbenzenesulfonyl)ure A

Synthesis of Dapagliflozin

Investigation Of Solubility Behavior Of Canagliflozin Hydrate Crystals Combining Crystallographic And Hirshfeld Surface Calculations

An Efficient Method for Synthesis of Bexagliflozin and Its Carbon-13 Labeled Analogue

Synthetic Approaches to Gliflozins: A Comprehensive Overview

Rapid Identification of Dapagliflozin Intermediate and Its Isomer by HPLC-IT-TOF MS

Synthesis and characterization of related substances of Azilsartan Kamedoxomil

Study of Hot Melt Granulation to Improve Dissolution Rate of Empagliflozin

Synthesis of New Derivatives of Berberine Canagliflozin and Study of Their Antibacterial Activity and Mechanism

Synthesis and Biological Evaluation of Novel Benzyl-Substituted (S)-Phenylalanine Derivatives As Potent Dipeptidyl Peptidase 4 Inhibitors.

Synthesis of 4-thiosubstituted flavan derivatives and their hypoglycemic activities

Transforming canagliflozin solubility using lipidic carrier and its pharmacokinetic study

C‐Aryl Glycosylation via Interrupted Pummerer Rearrangement

Synthesis of C4‐Acyl‐tetrofuranosides and C5‐Acyl‐pentopyranosides Enabled by the Liebeskind‐Srogl Cross‐Coupling Reaction

The Structural Revision and Total Synthesis of Carambolaflavone A.

[Design, synthesis and hypoglycemic activity of alpha-benzylsuccinic acid derivatives]

Mutagenic and genotoxic in silico QSAR prediction of dimer impurity of gliflozins; canagliflozin, dapaglifozin, and emphagliflozin and in vitro evaluation by Ames and micronucleus test

Synthesis, Crystal structure, Spectral analysis, DFT calculations, Docking studies, in vitro biological activity evaluation and in silico drug-likeness prediction of a novel L-xylose derivative